Phytoconstituents of Withania somnifera (L.) Dunal (Ashwagandha) unveiled potential cerebroside sulfotransferase inhibitors: insight through virtual screening, molecular dynamics, toxicity, and reverse pharmacophore analysis – PubMed Black Hawk Supplement
BLACK HAWK: Best ashwagandha supplement for immune system
Published article
Cerebroside sulfotransferase (CST) is considered as therapeutic target for substrate reduction therapy (SRT) for metachromatic leukodystrophy (MLD). The present study evaluates the therapeutic potential of 57 phytoconstituents of Withania somnifera against CST. Using binding score cutoff ≤-7.0 kcal/mol, top 10 compounds were screened and after ADME and toxicity-based screening, Withasomidienone, 2,4-methylene-cholesterol, and 2,3-Didehydrosomnifericin were identified as safe and potent drug…
Black Hawk Supplements, best supplements in the UK
Phytoconstituents of Withania somnifera (L.) Dunal (Ashwagandha) unveiled potential cerebroside sulfotransferase inhibitors: insight through virtual screening, molecular dynamics, toxicity, and reverse pharmacophore analysis
Nivedita Singh et al. J Biol Eng. .
Abstract
Cerebroside sulfotransferase (CST) is considered as therapeutic target for substrate reduction therapy (SRT) for metachromatic leukodystrophy (MLD). The present study evaluates the therapeutic potential of 57 phytoconstituents of Withania somnifera against CST. Using binding score cutoff ≤-7.0 kcal/mol, top 10 compounds were screened and after ADME and toxicity-based screening, Withasomidienone, 2,4-methylene-cholesterol, and 2,3-Didehydrosomnifericin were identified as safe and potent drug candidates for CST inhibition. Key substrate binding site residues involved in interaction were LYS82, LYS85, SER89, TYR176, PHE170, PHE177. Four steroidal Lactone-based withanolide backbone of these compounds played a critical role in stabilizing their position in the active site pocket. 100 ns molecular dynamics simulation and subsequent trajectory analysis through structural deviation and compactness, principal components, free energy landscape and correlation matrix confirmed the stability of CST-2,3-Didehydrosomnifericin complex throughout the simulation and therefore is considered as the most potent drug candidate for CST inhibition and Withasomidienone as the second most potent drug candidate. The reverse pharmacophore analysis further confirmed the specificity of these two compounds towards CST as no major cross targets were identified. Thus, identified compounds in this study strongly present their candidature for oral drug and provide route for further development of more specific CST inhibitors.
Keywords: Ashwagandha; Cerebroside sulfotransferase (CST); Inhibitor; Metachromatic leukodystrophy (MLD); Substrate reduction therapy (SRT).
© 2024. The Author(s).
Similar articles
-
Li W, Zech I, Gieselmann V, Müller CE. Li W, et al. J Chromatogr A. 2015 Aug 14;1407:222-7. doi: 10.1016/j.chroma.2015.06.053. Epub 2015 Jun 26. J Chromatogr A. 2015. PMID: 26163931
-
Kumar P, Banik SP, Goel A, Chakraborty S, Bagchi M, Bagchi D. Kumar P, et al. J Am Nutr Assoc. 2024 Feb;43(2):115-130. doi: 10.1080/27697061.2023.2228863. Epub 2023 Jul 6. J Am Nutr Assoc. 2024. PMID: 37410676 Review.
-
Deshpande SH, Muhsinah AB, Bagewadi ZK, Ankad GM, Mahnashi MH, Yaraguppi DA, Shaikh IA, Khan AA, Hegde HV, Roy S. Deshpande SH, et al. Molecules. 2023 Jan 22;28(3):1117. doi: 10.3390/molecules28031117. Molecules. 2023. PMID: 36770785 Free PMC article.
References
-
- Kurtzberg J. Gene therapy offers new hope for children with metachromatic leukodystrophy. Lancet. 2022;399:338–9 https://dukespace.lib.duke.edu/dspace/handle/10161/24562 . – DOI
-
- Shaimardanova AA, Chulpanova DS, Solovyeva VV, Mullagulova AI, Kitaeva KV, Allegrucci C, et al. Metachromatic Leukodystrophy: diagnosis, modeling, and treatment approaches. Front Med (Lausanne). 2020;7:1–17. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606900/ . Cited 2023 Dec 3.
-
- Guo Z, Li B, Cheng LT, Zhou S, McCammon JA, Che J. Identification of protein-ligand binding sites by the level-set variational implicit-solvent approach. J Chem Theory Comput. 2015;11:753–65. https://doi.org/10.1021/ct500867u . Cited 2024 Jan 5. – DOI
-
- Laugwitz L, Santhanakumaran V, Spieker M, Boehringer J, Bender B, Gieselmann V, et al. Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long-term follow-up and review of the literature. JIMD Rep. 2022;63:292–302. https://doi.org/10.1002/jmd2.12293 . Cited 2024 Feb 4. – DOI
-
- Sessa M, Lorioli L, Fumagalli F, Acquati S, Redaelli D, Baldoli C, et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial. Lancet. 2016;388:476–87. https://pubmed.ncbi.nlm.nih.gov/27289174/ . Cited 2024 Feb 4. – DOI
Grants and funding
BLACK HAWK: Best lions mane supplement for dads
Read the original publication: